MicroRNA miR-16-1 regulates CCNE1 (cyclin E1) gene expression in human cervical cancer cells

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 9, 2015, Pages 15999-16006

  Zubillaga Guerrero, Ma Isabel ^a   Alarcón Romero, Luz del Carmen ^a   Illades Aguiar, Berenice ^a   Flores Alfaro, Eugenia ^a   Bermúdez Morales, Víctor Hugo ^b   Deas, Jessica ^b   Peralta Zaragoza, Oscar ^b  

^a UNIVERSIDAD AUTÓNOMA DE GUERRERO   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

CCNE1; Cervical cancer; HPV; MicroRNAs; MiR 16 1; SiRNAs

Indexed keywords

CYCLIN E; CYCLIN E1; MICRORNA 16; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER;

EID: 84946606635     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bartel PD. MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell 2004; 116: 281-297.
2. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 2005; 353: 1768-1771.
3. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI, Alder H, Volinia S, Rassenti L, Liu X, Liu CG, Kipps TJ, Negrini M and Croce CM. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A 2008; 105: 5166-5171.
4. Zheng ZM and Wang X. Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta 2011; 1809: 668-677.
5. Linsley PS, Schelter J, Burchard J, Kibukawa M, Martin MM, Bartz SR, Johnson JM, Cummins JM, Raymond CK, Dai H, Chau N, Cleary M, Jackson AL, Cartelon M and Lim L. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 2007; 27: 2240-2252.
6. Chen RW, Bemis LT, Amato CM, Myint H, Tran H, Birks DK, Eckhardt SG and Robinson WA. Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. Blood 2008; 112: 822-829.
7. Wang F, Xiang D, Zhou Y and Zhang Y. Down-regulation of the cyclin E1 oncogene expression by microRNA-16-1 induces cell cycle arrest in human cancer cells. BMB Rep 2009; 42: 725-730.
8. Wang S, Tang S, Le Y, Lu R, Rader JS, Meyers C and Zheng ZM. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008; 3: e2557.
9. Sauer K and Lehner CF. The role of cyclin E in the regulation of entry into S phase. Prog Cell Cycle Res 1995; 1: 125-139.
10. Hu W, Nevzorova YA, Haas U, Moro N, Sicinski P, Geng Y, Barbacid M, Trautwein C and Liedtke C. Concurrent deletion of cyclin E1 and cyclin-dependent kinase 2 in hepatocytes inhibits DNA replication and liver regeneration in mice. Hepatology 2014; 59: 651-660.
11. Sheu JJ, Choi JH, Guan B, Tsai FJ, Hua CH, Lai MT, Wang TL and Shih IeM. Rsf-1, a chromatin remodelling protein, interacts with cyclin E1 and promotes tumour development. J Pathol 2013; 229: 559-568.
12. Nakayama N, Nakayama K, Shamima Y, Ishikawa M, Katagiri A, lida K and Miyazaki K. Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer. Cancer 2010; 116: 2621-2634.
13. Coradini D, Boracchi P, Oriana S, Biganzolo E and Ambrogi G. Differential expression of genes involved in the epigenetic regulation of cell identity in normal human mammary cell commitment and differentiation. Chin J Cancer 2014; 33: 501-510.
14. Erlandsson F, Martinsson-Ahlzen H, Wallin K, Hellström AC, Andersson S and Zetterberg A. Parallel cyclin E and cyclinA expression in neoplastic lesions of the uterine cervix. Br J Cancer 2006; 94: 1045-1050.
15. Lui WO, Pourmand N, Patterson BK and Fire A. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 2007; 67: 6031-6043.
16. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, HwangSY, Kim WY, Kim TJ, Lee JH, Kim BG and Baue DS. Altered microRNAs expression in cervical carcinomas. Cancer Res 2008; 14: 2535-2542.
17. Pereira PM, Marques JP, Soares AR, Carreto L and Santos MA. MicroRNA expression variability in human cervical tissues. PLoS One 2010; 5: e11780-e11780.
18. Wang X, Wang HK, Li Y, Hafner M, Banerjee NS, Tang S, Briskin D, Meyers C, Chow LT, Vie X, Tuschl T and Zheng ZM. MicroRNAs are biomarkers of oncogenic human papillomavirus infections. Proc Natl Acad Sci U S A 2014; 111: 1-6.
19. SiRNA at Whitehead. SiRNA target finder and design tool (2004). http://jura.wi.mit.edu/bioc/siRNAext/Accessed: March 26, 2014.
20. Gregory RI and Shiekhattar R. MicroRNA Biogenesis and cancer. Cancer Res 2005; 65: 3509-3512.
21. Salazar-León J, Reyes-Román F, Meneses-Acosta A, Merchant H, Lagunas-Martínez A, Meda-Monzón E, Pita-López ML, Gómez-Cerón C, Bermúdez-Morales VH, Madrid-Marina V and Peralta-Zaragoza O. Silencing of HPV16 E6 and E7 oncogenic activities by small interference RNA induces autophagy and apoptosis in human cervical cancer cells. J Nucleic Acids Investig 2011; 2: 59-69.
22. Peralta-Zaragoza O, De-la-O-Gómez F, Deas J, Fernández-Tilapa G, Fierros-Zarate G del S, Gómez-Cerón C, Burguete-García A, Torres-Poveda VH, Rodríguez-Dorantes M, Pérez-Plasencia C and Madrid-Marina V. Selective silencing of gene target expression by siRNA expression plasmids in human cervical cancer cells. Methods Mol Biol 2015; 1249: 153-171.
23. Thorland EC, Myers SL, Gostout BS and Smith DI. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 2003; 22: 1225-1237.
24. Ofir M, Hacohen D and Ginsberg D. miR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Mol Cancer Res 2011; 9: 440-447.
25. Schmitz M, Driesch C, Jansen L, Runnebaum IB and Dürst M. Non-Random Integration of the HPV Genome in Cervical Cancer. PLoS One 2012; 7: e39632.
26. Ferber MJ, Thorland EC, Brink AA, Rapp AK, Phillips LA, McGovern R, Gostout BS, Cheung TH, Chung TKH, Fu WY and Smith DI. Pre-ferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene 2003; 22: 7233-7472.
27. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A and Mendell JT. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008; 40: 43-50.
28. Nguyen C and Münger K. Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes. Virology 2008; 380: 21-25.
29. Kaddar T, Roualult JP, Chien WW, Chebel A, Gadoux M, Salles G, Ffrench M and Mgaud JP. Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation. Biol Cell 2009; 101: 511-524.
30. Lu X, Lin Q, Lin M, Duan P, Ye L, Chen J, Chen X, Zhang L and Xue X. Multiple-Integrations of HPV16 Genome and Altered Transcription of Viral Oncogenes and Cellular Genes Are Associated with the Development of Cervical Cancer. PLoS One 2014; 9: e97588-e97597.
31. Popescu NC, DiPaolo JA and Amsbaugh SC. Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenet Cell Genet 1987; 44: 58-62.